Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay ...

Purdue Pharma, manufacturer of the highly addictive pain killer oxycontin, declared bankruptcy in 2019 and entered into a multibillion dollar settlement over their sales practices with the ...

According to CBS News, Purdue Pharma will be left bankrupt from the 2025 settlement. According to Purdue’s website, the company dedicated itself to a “restructure” over the past few years.

Purdue Pharma and the Sackler family who own the company have proposed a new $7.4 billion settlement to resolve thousands of lawsuits claiming they played a role in driving the opioid addiction ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window ...

A judge in the US has approved the sale of Purdue Pharma’s consumer health business Avrio, part of the bankruptcy proceedings related to the drugmaker’s proposed $10 billion settlement of ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...